[Biologically active additives in health prophylaxis of medical workers]. 2010

N F Kushnerova, and S E Fomenko, and Iu A Rakhmanin, and L N Lesnikova, and V G Sprygin, and T V Kushnerova, and V Iu Merzliakov

The aim of the investigation was to use the biologically active additive (BAD) Kalifen to prevent metabolic disturbances in medical workers during their occupational activity. Female physicians aged 40-50 years were examined. Group 1 (control) included 20 age-matched healthy female donors. Group 2 comprised 27 female physicians (anesthesiologists and surgeons) daily exposed to stresses (chemical, psychoemotional, work-related, etc.) who were asked after blood biochemical tests to daily take the BAD Kalifen in a dose of 2.5 ml after a meal (they made up Group 3), which is equal to the daily prophylactic dose in 100 mg of total polyphenols. The plasma tested before an experiment showed hypertriglyceridemia and hypercholesterolemia, suppressed hepatic etherifying function, imbalance of the fractional content of phospholipids, exhaustion of the antioxidative system, increased lipid peroxidation, and impaired erythrocytic membrane permeability. The prophylactic use of the BAD Kalifen eliminates stress-induced metabolic disturbances and increases occupational and biological longevity in the able-bodied population.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010636 Phenols Benzene derivatives that include one or more hydroxyl groups attached to the ring structure.
D010822 Physicians, Women Women licensed to practice medicine. Women Physicians,Physician, Woman,Physicians, Woman,Woman Physician,Woman Physicians
D005260 Female Females
D005419 Flavonoids A group of phenyl benzopyrans named for having structures like FLAVONES. 2-Phenyl-Benzopyran,2-Phenyl-Chromene,Bioflavonoid,Bioflavonoids,Flavonoid,2-Phenyl-Benzopyrans,2-Phenyl-Chromenes,2 Phenyl Benzopyran,2 Phenyl Benzopyrans,2 Phenyl Chromene,2 Phenyl Chromenes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006937 Hypercholesterolemia A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population. Hypercholesteremia,Elevated Cholesterol,High Cholesterol Levels,Cholesterol Level, High,Cholesterol Levels, High,Cholesterol, Elevated,Cholesterols, Elevated,Elevated Cholesterols,High Cholesterol Level,Hypercholesteremias,Hypercholesterolemias,Level, High Cholesterol,Levels, High Cholesterol
D006943 Hyperglycemia Abnormally high BLOOD GLUCOSE level. Postprandial Hyperglycemia,Hyperglycemia, Postprandial,Hyperglycemias,Hyperglycemias, Postprandial,Postprandial Hyperglycemias
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous

Related Publications

N F Kushnerova, and S E Fomenko, and Iu A Rakhmanin, and L N Lesnikova, and V G Sprygin, and T V Kushnerova, and V Iu Merzliakov
July 1998, Voenno-meditsinskii zhurnal,
N F Kushnerova, and S E Fomenko, and Iu A Rakhmanin, and L N Lesnikova, and V G Sprygin, and T V Kushnerova, and V Iu Merzliakov
January 2002, Voprosy pitaniia,
N F Kushnerova, and S E Fomenko, and Iu A Rakhmanin, and L N Lesnikova, and V G Sprygin, and T V Kushnerova, and V Iu Merzliakov
September 2002, Voenno-meditsinskii zhurnal,
N F Kushnerova, and S E Fomenko, and Iu A Rakhmanin, and L N Lesnikova, and V G Sprygin, and T V Kushnerova, and V Iu Merzliakov
January 2002, Gigiena i sanitariia,
N F Kushnerova, and S E Fomenko, and Iu A Rakhmanin, and L N Lesnikova, and V G Sprygin, and T V Kushnerova, and V Iu Merzliakov
March 2024, Problemy sotsial'noi gigieny, zdravookhraneniia i istorii meditsiny,
N F Kushnerova, and S E Fomenko, and Iu A Rakhmanin, and L N Lesnikova, and V G Sprygin, and T V Kushnerova, and V Iu Merzliakov
January 1998, Gigiena i sanitariia,
N F Kushnerova, and S E Fomenko, and Iu A Rakhmanin, and L N Lesnikova, and V G Sprygin, and T V Kushnerova, and V Iu Merzliakov
January 1996, Voprosy pitaniia,
N F Kushnerova, and S E Fomenko, and Iu A Rakhmanin, and L N Lesnikova, and V G Sprygin, and T V Kushnerova, and V Iu Merzliakov
January 1997, Klinicheskaia meditsina,
N F Kushnerova, and S E Fomenko, and Iu A Rakhmanin, and L N Lesnikova, and V G Sprygin, and T V Kushnerova, and V Iu Merzliakov
January 1988, Pediatriia,
N F Kushnerova, and S E Fomenko, and Iu A Rakhmanin, and L N Lesnikova, and V G Sprygin, and T V Kushnerova, and V Iu Merzliakov
May 1994, Annals of the New York Academy of Sciences,
Copied contents to your clipboard!